Women at higher risk than men of kidney damage after heart imaging test

Women are at higher risk than men of developing kidney damage after undergoing a coronary angiogram, according to a Henry Ford Hospital study.

Researchers found that women are 60 percent more likely than men to develop radiocontrast-induced (RCIN), an adverse side effect that causes within 24 to 72 hours after patients are administered an iodine contrast dye during the common heart imaging test.

This is believed to be the first study in which researchers investigated whether gender played a role in patients developing RCIN after undergoing a coronary angiogram. RCIN is the third-leading cause of hospital-acquired in the United States, after surgery and hypertension.

The study is being presented Wednesday at the National Kidney Foundation's Spring Clinical Meeting in Las Vegas.

While researchers say further study is needed to explain the gender risk, they theorize that a woman's size may be a factor, says Javier Neyra, M.D., an Internal Medicine resident at Henry Ford and the study's principal investigator.

"Because men and women patients receive the same amount of dye during a coronary angiogram, it's possible the amount is just too much for a woman's body to handle given her smaller size," Dr. Neyra says. "Perhaps a woman's height and weight ought to be factored into the dosage."

Dr. Neyra says the contrast dye may cause the kidney's to narrow, thus causing damage to the organ. He says women with a history of should consult with their physician about undergoing heart imaging tests using contrast dyes.

Contrast dye is used to improve the visibility of internal body structures during an imaging test. In a coronary angiogram, the dye enhances images of the heart's blood vessels and chambers.

In the Henry Ford study, researchers followed 1,211 patients who received a from January 2008 to December 2009. Nearly 20 percent of women developed RCIN compared to 13.6 percent of men.

Dr. Neyra says other contributing factors in the gender risk could be age, hormonal levels and other chronic conditions. "We just don't know without further study," he says.

Related Stories

Recommended for you

New hope for rare disease drug development

8 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

11 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

12 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.